Abstract
Background Breastfeeding is hypothesised to benefit child health and cognitive functioning by providing long-chain polyunsaturated fatty acids (LC-PUFA), which are essential for brain development. In 2007, Caspi et al. found evidence in two cohorts for an interaction between genetic variation in the FADS2 gene (a gene involved in fatty acid metabolism) and breast feeding on IQ. However, subsequent studies have provided mixed evidence for the existence of an interaction.
Objective To investigate the relationship between genetic variation in the FADS2 region, breastfeeding, and their interaction on traits putatively affected by their interplay in a large, population-based cohort with appropriate control for confounders in genetic associations.
Methods We tested for the interaction in up to 335,650 individuals from the UK Biobank, over a range of cognitive functioning tests, as well as educational attainment and other traits thought to be influenced by breastfeeding, including cardiometabolic traits, reproductive success, and atopic allergy.
Results FADS2 alleles associated with an increase in docosahexaenoic acid (DHA) in blood serum (the C allele of rs174575) were associated with decreased verbal-numerical reasoning ( p= 2.28× 10−5) and triglycerides ( p= 1. 40× 10−41), increased reproductive success ( p= 3. 40× 10−5), total cholesterol ( p= 5. 28× 10−36), HDL ( p= 1. 42× 10− 51), and LDL cholesterol ( p= 1. 46× 10− 21). We observed no evidence of an interaction in any of the traits, regardless of the modelling strategy.
Conclusions We failed to replicate any breastfeeding by genotype interactions on any cognitive or non-cognitive traits. We postulate that the previous positive findings are likely to be spurious, perhaps due to lack of appropriate control for latent population structure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by an NHMRC Ideas Grant [APP1157714]. UK Biobank is generously supported by its founding funders the Wellcome Trust and UK Medical Research Council, as well as the British Heart Foundation, Cancer Research UK, Department of Health, Northwest Regional Development Agency and Scottish Government. D.M.E. is supported by an NHMRC Leadership Fellowship [APP2017942]. N.M.W is supported by an NHMRC Emerging Leadership Fellowship [APP2008723]. G.H. and G.D.S. were supported by the UK Medical Research Council [MC_UU_00032/01].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank gave ethical approval for this work (application 53641)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Sources of support for the work: this work was supported by an NHMRC Ideas Grant [APP1157714]. UK Biobank is generously supported by its founding funders the Wellcome Trust and UK Medical Research Council, as well as the British Heart Foundation, Cancer Research UK, Department of Health, Northwest Regional Development Agency and Scottish Government. D.M.E. is supported by an NHMRC Leadership Fellowship [APP2017942]. N.M.W is supported by an NHMRC Emerging Leadership Fellowship [APP2008723]. G.H. and G.D.S. were supported by the UK Medical Research Council [MC_UU_00032/01]. The analyses described in this manuscript were conducted under the UK Biobank application 53641.
Data share statement: the UK Biobank data described in the manuscript is available to all bona fide research upon application and approval. Code book and analytic code will be made publicly and freely available without restrictions at https://github.com/GiulioCentorame/FADS-by-breastfeeding/
List of abbreviations: AA, arachidonic acid; ALSPAC, Avon Longitudinal Study of Parents and Children; DBP, diastolic blood pressure; DHA, docosahexaenoic acid; EPA, eicosapentaneoic acid; E-risk, Environmental Risk Longitudinal Twin Study; GWAS, genome-wide association study; HDL, high-density lipoprotein; LA, linoleic acid; LC-PUFA, long-chain polyunsaturated fatty acids; LD, linkage disequilibrium; LDL, low-density lipoprotein; PC, principal component; PUFA, polyunsaturared fatty acids; SBP, systolic blood pressure; SES, socioeconomic status; SNP, single nucleotide polymorphism; TDI, Townsend deprivation index
Data Availability
The UK Biobank data described in the manuscript is available to all bona fide research upon application and approval. Code book and analytic code are available online at https://github.com/GiulioCentorame/FADS-by-breastfeeding/
